Comorbid conditions | Analysis of 90-day mortality n = 332 | Analysis of overall mortality n = 340 | ||||||
---|---|---|---|---|---|---|---|---|
Patients with condition (%) | Hazard ratio | 95% confidence interval | P-value | Patients with condition (%) | Sub-Hazard ratio | 95% confidence interval | P-value | |
Myocardial infarctionb c | 1.8 | NAa | 1.8 | 1.3 | (0.8–2.2) | 0.3 | ||
Coronary artery disease (no infarction) | 18.4 | 0.4 | (0.1–1.4) | 0.17 | 18.5 | 1.1 | (0.8–1.5) | 0.7 |
Congestive heart failureb c | 4.2 | 0.8 | (0.1–5.6) | 0.8 | 4.4 | 2 | (1.4–2.9) | < 0.001 |
Peripheral vascular diseaseb c | 3.3 | NAa | 3.2 | 1.1 | (0.6–2.2) | 0.7 | ||
Cerebrovascular diseaseb | 2.7 | 1.2 | (0.16–8.8) | 0.9 | 2.7 | 2 | (1.1–3.4) | 0.015 |
Dementiab | 0.9 | 4 ( | 0.5–29) | 0.17 | 1.2 | 2 | (0.5–7.6) | 0.3 |
Chronic obstructive pulmonary diseaseb | 15.1 | 1.5 | (0.6–3.4) | 0.3 | 13.5 | 1.6 | (1.1–2.2) | 0.007 |
Connective tissue diseaseb | 3.6 | 3.1 | (0.9–10) | 0.06 | 3.8 | 1.9 | (1.1–3.4) | 0.03 |
Peptic ulcer diseaseb | 6 | 1.7 | (0.5–5.5) | 0.4 | 5.3 | 1.5 | (0.8–2.6) | 0.2 |
Diabetes without complicationsb | 23.8 | 0.6 | (0.2–1.4) | 0.2 | 24.4 | 0.95 | (0.7–1.3) | 0.8 |
Diabetes with complicationsb | 8.1 | 0.7 | (0.2–3) | 0.2 | 7.9 | 1.6 | (1.1–2.4) | 0.016 |
Hemiplegiab | 0.6 | NAa | 0.6 | 0.9 | (0.1–6.1) | 0.9 | ||
Renal disease (creatinine > 3 mg/dL)b | 2.1 | 1.5 | (0.2–11) | 0.7 | 1.8 | 5.1 | (0.9–30) | 0.07 |
Renal disease (creatinine ≥1.5 mg/dL)c | 15.4 | 4.2 | (2.1–8.5) | < 0.001 | 15.9 | 2.4 | (1.6–3.5) | < 0.001 |
Leukemiab c | None | NA | None | NA | ||||
Lymphomab c | None | NA | None | NA | ||||
Non-metastatic solid tumorb c | 2.3 | 2.4 | (0.6–10.1) | 0.2 | 2.1 | 1.8 | (06–5) | 0.3 |
Metastatic solid tumorb c | 0.3 | NAa | 0.3 | 6.8 | (5.1–9.1) | < 0.001 | ||
AIDSb | 0.3 | NAa | 0.3 | 4.1 | (3.3–5.2) | < 0.001 | ||
Epilepsyc | 3.3 | NAa | 3.5 | 1.1 | (0.6–2.3) | 0.7 | ||
Substance abuse other than alcoholismv | 19.9 | 1.3 | (0.6–2.9) | 0.5 | 19.4 | 1.5 | (1.1–2) | 0.018 |